Literature DB >> 35559411

LINC01272 activates epithelial-mesenchymal transition through miR-153-5p in Crohn's disease.

Lin Fang1, Mengcheng Hu1, Fei Xia1, Wenxia Bai1.   

Abstract

OBJECTIVES: Long noncoding RNAs (lncRNAs) have different functions in different diseases. There is little research on the functions of lncRNAs in Crohn's disease (CD). By using RNA-seq technology, we identified a lncRNA associated with Crohn's disease. However, the mechanism of lncRNA regulation remains unknown. This study aimed to determine the association of LINC01272 with epithelial cell-mesenchymal transition and the underlying mechanism in CD.
METHODS: RNA was detected by qRT-PCR. The interaction of protein and RNA was determined by RNA binding protein immunoprecipitation. Luciferase reporter assays were used to detect the targeted miRNA of LINC01272. Tissue fibrosis was observed by Masson and H&E staining. Protein expression was determined by western blotting and immunofluorescence.
RESULTS: LINC01272 was highly expressed in patients with CD. Knockdown of LINC01272 inhibited TGF-β1-induced epithelial-mesenchymal transition (EMT). Additionally, LINC01272 regulated TGF-β1-induced EMT through the miR-153-5p axis, and knockdown of LINC01272 inhibited EMT in CD mice in vivo.
CONCLUSION: LINC01272 activated the epithelial-mesenchymal transition through miR-153-5p in CD. AJTR
Copyright © 2022.

Entities:  

Keywords:  Crohn’s disease; EMT; LINC01272; miR-153-5p

Year:  2022        PMID: 35559411      PMCID: PMC9091119     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   3.940


  39 in total

1.  Epithelial-mesenchymal transition.

Authors:  Derek C Radisky
Journal:  J Cell Sci       Date:  2005-10-01       Impact factor: 5.285

2.  S100A4 expression is increased in stricture fibroblasts from patients with fibrostenosing Crohn's disease and promotes intestinal fibroblast migration.

Authors:  Michael F Cunningham; Neil G Docherty; John P Burke; P Ronan O'Connell
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-05-20       Impact factor: 4.052

Review 3.  Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches.

Authors:  Julia Beermann; Maria-Teresa Piccoli; Janika Viereck; Thomas Thum
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

Review 4.  Crohn's disease.

Authors:  María Pilar Ballester Ferré; Marta Maia Boscá-Watts; Miguel Mínguez Pérez
Journal:  Med Clin (Barc)       Date:  2017-12-13       Impact factor: 1.725

5.  Distinct inflammatory mechanisms mediate early versus late colitis in mice.

Authors:  David M Spencer; Geertruida M Veldman; Subhashis Banerjee; Joseph Willis; Alan D Levine
Journal:  Gastroenterology       Date:  2002-01       Impact factor: 22.682

6.  Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix.

Authors:  Kevin K Kim; Matthias C Kugler; Paul J Wolters; Liliane Robillard; Michael G Galvez; Alexis N Brumwell; Dean Sheppard; Harold A Chapman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-21       Impact factor: 11.205

Review 7.  Pathogenesis of fibrostenosing Crohn's disease.

Authors:  Jiannan Li; Ren Mao; Satya Kurada; Jie Wang; Sinan Lin; Jyotsna Chandra; Florian Rieder
Journal:  Transl Res       Date:  2019-03-26       Impact factor: 7.012

Review 8.  Crohn's disease.

Authors:  Joana Torres; Saurabh Mehandru; Jean-Frédéric Colombel; Laurent Peyrin-Biroulet
Journal:  Lancet       Date:  2016-12-01       Impact factor: 79.321

Review 9.  Crohn's Disease: Diagnosis and Management.

Authors:  Brian Veauthier; Jaime R Hornecker
Journal:  Am Fam Physician       Date:  2018-12-01       Impact factor: 3.292

10.  Pro-inflammatory miR-223 mediates the cross-talk between the IL23 pathway and the intestinal barrier in inflammatory bowel disease.

Authors:  Huiling Wang; Kang Chao; Siew Chien Ng; Alfa Hc Bai; Qiao Yu; Jun Yu; Manying Li; Yi Cui; Minhu Chen; Ji-Fan Hu; Shenghong Zhang
Journal:  Genome Biol       Date:  2016-03-30       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.